Literature DB >> 12963212

Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study.

Sunil M Prasad1, Hersh S Maniar, Michael D Diodato, Richard B Schuessler, Ralph J Damiano.   

Abstract

BACKGROUND: Alternative energy sources have been proposed for the transvenous and surgical treatment of atrial fibrillation. This study examined the physiologic consequences of a novel energy source, bipolar radiofrequency energy, in a chronic animal model in order to determine its ability to produce transmural lesions on the beating heart.
METHODS: Five dogs underwent baseline pacing from the following target areas: right and left atrial appendage, superior and inferior vena cavae, and right and left pulmonary veins. A cuff of atrial myocardium, proximal to the target tissue was clamped and ablated between the arms of the bipolar radiofrequency energy device. Tissue conductance was used as a transmural indicator. After ablation, the pacing protocol was repeated. Baseline and postablation pulmonary vein flows were measured. Animals were survived for 30 days, and permanent electrical isolation was evaluated by pacing, epicardial mapping, and histology.
RESULTS: Mean ablation time was 5.0 +/- 1.8 seconds and mean peak tissue temperature was 46.7 degrees C +/- 2.8 degrees C. All lesions (30/30) acutely and permanently isolated atrial tissue. There was no change in pulmonary vein flow. Mapping studies with pacing of atrial tissue on both sides of the lesion confirmed isolation. Histology demonstrated that all lesions were linear, continuous, and transmural with no thrombus formation or stenosis.
CONCLUSIONS: Bipolar radiofrequency energy rapidly produced permanent transmural linear lesions on the beating heart. Measurement of tissue conductance reliably predicted transmural lesions. This new technology may enable the development of a less invasive, surgical approach to atrial fibrillation.

Entities:  

Mesh:

Year:  2003        PMID: 12963212     DOI: 10.1016/s0003-4975(03)00716-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  33 in total

Review 1.  Management of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: Review of the Literature.

Authors:  Ali J Khiabani; Taylan Adademir; Richard B Schuessler; Spencer J Melby; Marc R Moon; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Nov/Dec

2.  Chronic performance of a novel radiofrequency ablation device on the beating heart: Limitations of conduction delay to assess transmurality.

Authors:  Anson M Lee; Abdulhameed Aziz; Kal L Clark; Richard B Schuessler; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-02       Impact factor: 5.209

Review 3.  Ablation technology for the surgical treatment of atrial fibrillation.

Authors:  Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  ASAIO J       Date:  2013 Sep-Oct       Impact factor: 2.872

4.  Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery.

Authors:  Lindsey L Saint; Ralph J Damiano; Phillip S Cuculich; Tracey J Guthrie; Marc R Moon; Nabil A Munfakh; Hersh S Maniar
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-30       Impact factor: 5.209

5.  Bipolar Radiofrequency Ablation on Explanted Human Hearts: How to Ensure Transmural Lesions.

Authors:  Ali J Khiabani; Robert M MacGregor; Joshua L Manghelli; Chawannuch Ruaengsri; Daniel I Carter; Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2020-06-06       Impact factor: 4.330

Review 6.  [New developments for surgical ablation of atrial fibrillation].

Authors:  W Hemmer; J O Böhm
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-06

7.  Biatrial lesion sets.

Authors:  Ralph J Damiano; Rochus K Voeller
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

Review 8.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

9.  NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION.

Authors:  Spencer J Melby; Andreas Zierer; Jordon G Lubahn; Marci S Bailey; James L Cox; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2008-05-01

Review 10.  Curing atrial fibrillation: Two decades of progress.

Authors:  N A Mark Estes; Ralph J Damiano
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.